- Home
- FNWB vs IOBT Comparison
FNWB vs IOBT Comparison
Compare FNWB & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNWB | IOBT |
|---|---|---|
| Founded | 1923 | 2014 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.9M | 57.2M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FNWB | IOBT |
|---|---|---|
| Price | $9.96 | $0.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $13.50 | $3.50 |
| AVG Volume (30 Days) | 29.6K | ★ 835.6K |
| Earning Date | 01-28-2026 | 11-14-2025 |
| Dividend Yield | ★ 1.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $54,052,000.00 | N/A |
| Revenue This Year | $31.86 | N/A |
| Revenue Next Year | $10.64 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $6.05 | $0.32 |
| 52 Week High | $12.10 | $2.79 |
Technical Indicators
Market Signals| Indicator | FNWB | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 64.85 | 51.48 |
| Support Level | $9.80 | $0.59 |
| Resistance Level | $10.14 | $0.88 |
| Average True Range (ATR) | 0.21 | 0.08 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 46.15 | 75.21 |
Price Performance
Historical ComparisonAbout FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.